| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/03/1992 | US5093099 Flaky powder of zinc oxide and its composition for external use |
| 03/03/1992 | US5093043 Process for preparing nonionic surfactants |
| 03/03/1992 | CA1296634C Pharmaceutical formulations of ciprofloxacin |
| 03/03/1992 | CA1296633C Controlled release bases for pharmaceuticals |
| 03/03/1992 | CA1296631C Controlled-release composition |
| 03/03/1992 | CA1296630C Dual phase solvent carrier system |
| 03/03/1992 | CA1296628C Ethanol fill formulation for softgels containing vitamins, dietary supplements and the like |
| 03/01/1992 | WO1992004053A1 Homoconjugated immunoglobulins |
| 03/01/1992 | WO1992004048A2 Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies |
| 03/01/1992 | WO1992004016A1 Pharmaceutical composition of florfenicol |
| 03/01/1992 | CA2090317A1 Homoconjugated immunoglobulins |
| 03/01/1992 | CA2089375A1 Inhibition of metastatis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies |
| 03/01/1992 | CA2050063A1 Polyethylene glycol derivatives, their modified peptides, methods for producing them and use of the modified peptides |
| 02/26/1992 | EP0472327A1 Composition for eye drops |
| 02/26/1992 | EP0472144A2 Method for preparation of layered silicates of the magadiite type |
| 02/26/1992 | EP0471872A1 Antifungal gel formulations |
| 02/26/1992 | EP0471793A1 Improved forms of basic fibroblast growth factor |
| 02/26/1992 | EP0471792A1 Methods, reagents and test kits for determination of subpopulations of biological entities |
| 02/26/1992 | EP0471790A1 Method for localization and treatment of tumors and complexes therefor |
| 02/26/1992 | CN1058904A Coated solid medicament form having releasability in large intestine |
| 02/25/1992 | US5091512 Fibrinogen-specific monoclonal antibody |
| 02/25/1992 | US5091432 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use |
| 02/25/1992 | US5091379 Dermatitis, side effect reduction |
| 02/25/1992 | US5091373 Administering sterile injectable solution of water, doxorubicin or salts and cosolubilizing agent; lyophilization |
| 02/25/1992 | US5091372 Method of treating tumors with pharmaceutical composition containing anthracycline glycosides |
| 02/25/1992 | US5091365 Cyclic peptides as promoters of absorption on administration onto the mucosa |
| 02/25/1992 | US5091313 Antigenic epitopes of IgE present on B cell but not basophil surface |
| 02/25/1992 | US5091191 Pharmaceutical composition with improved dissolution property |
| 02/25/1992 | US5091189 Tablet contains 3-alkylxanthine, hydrophilic or hydrophobic polymers, and wax from the group consists of polyalkylene glycol |
| 02/25/1992 | US5091188 Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
| 02/25/1992 | US5091185 Growth hormones with release inhibiting coating of hydrolysed polyvinyl alcohol |
| 02/25/1992 | US5091176 Binding a peptide in aqueous solution to a polyether triol comprising at least 75% ethylene oxide units and having polyisocyanate end groups |
| 02/25/1992 | US5091171 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use |
| 02/25/1992 | US5091111 Mixtures of a non-ionic surfactant, an alcohol, a polyhydroxy alcohol and/or polyhydroxy alcohol esters and a hydrocarbon propellant |
| 02/25/1992 | CA1296459C Hydrogels with increased organic solvent soluble active agent loading capacity, their preparation and the use thereof |
| 02/25/1992 | CA1296253C Stabilized growth hormone compositions |
| 02/25/1992 | CA1296176C Desiccant and dehydration therewith |
| 02/21/1992 | WO1992003138A1 Improvements in or relating to organic compounds |
| 02/21/1992 | CA2065421A1 Organic compounds |
| 02/20/1992 | WO1992002560A1 Amphiphilic fluorine derivatives with telomeric structures; preparation and biomedical applications |
| 02/20/1992 | WO1992002531A1 Novel polyamine conjugated oligonucleotides |
| 02/20/1992 | WO1992002527A1 New carbohydrate-based anti-inflammatory agents |
| 02/20/1992 | WO1992002257A2 Renal-selective angiotensin ii antagonists for treatment of hypertension |
| 02/20/1992 | WO1992002256A1 Cyclodextrin complexes for neuraxial administration of drugs |
| 02/20/1992 | WO1992002255A1 New linker for bioactive agents |
| 02/20/1992 | WO1992002209A1 Method for preparing a bioadhesive galenical and galenical thereby obtained |
| 02/20/1992 | WO1992002133A1 Improved diagnostic and therapeutic compositions |
| 02/20/1992 | WO1992000106A3 Method of treatment and compositions therefore |
| 02/20/1992 | WO1991019736A3 Cancer-associated scm-recognition factor, preparation and method of use |
| 02/20/1992 | WO1991004059A3 Method and useful apparatus for preparing pharmaceutical compositions |
| 02/20/1992 | CA2088923A1 Amphiphilic fluorine derivatives with telomeric structures; preparation and biomedical applications |
| 02/20/1992 | CA2088489A1 Carbohydrate-based anti-inflammatory agents |
| 02/20/1992 | CA2087731A1 Novel polyamine conjugated oligonucleotides |
| 02/19/1992 | EP0471618A1 Calcitonin-containing emulsion for nasal administration |
| 02/19/1992 | EP0471309A1 Use of mixed micelles |
| 02/19/1992 | EP0471161A1 Spray container containing nitroglycerin in a hydrophilic aqueous composition |
| 02/19/1992 | EP0471084A1 Oil-in-water emulsion composition containing nonsteroidal antiphlogistic analgesic |
| 02/19/1992 | EP0418341A4 Percutaneous drug delivery system |
| 02/19/1992 | CN1058715A Solid oral forms of application containing ifosfamide as active substance |
| 02/18/1992 | WO1992003480A1 N-acetylcarboxymethylchitosan derivative and production thereof |
| 02/18/1992 | US5089603 Antigenic epitopes present on membrane-bound but not secreted iga |
| 02/18/1992 | US5089531 Compositions incorporating a salt of monoester of citric acid and a method for synthesizing the monoester |
| 02/18/1992 | US5089527 Pentamidine solutions |
| 02/18/1992 | US5089503 Aqueous alkaline solutions stored in vials with sodium phosphate washed rubber closures; nonsettling, injectable |
| 02/18/1992 | US5089482 Containing estradiol and/or progesterone; absorption |
| 02/18/1992 | US5089276 Calcium pantothenate composite |
| 02/18/1992 | US5089265 Mixture with product of lactobacillus fermentation of rice bran; for deodorizing |
| 02/18/1992 | US5089261 Preparation of a polymer/interleukin-2 conjugate |
| 02/18/1992 | US5088505 Contraceptive implant |
| 02/18/1992 | US5088499 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
| 02/18/1992 | US5088314 Gas detecting method and system |
| 02/18/1992 | CA2049374A1 Use of mixed micelles |
| 02/18/1992 | CA1295948C Perfluorohydrocarbons as vehicles for administering drugs |
| 02/18/1992 | CA1295944C Pharmaceutical composition with antiviral or antitumor activity |
| 02/18/1992 | CA1295941C Sustained-release formulation comprising a hydrophobic polymer system |
| 02/18/1992 | CA1295796C Biodegradable matrix and methods for producing same |
| 02/14/1992 | CA2048942A1 Composition for eye drops |
| 02/12/1992 | EP0470872A1 Polysaccharide article and use thereof |
| 02/12/1992 | EP0470703A1 Thermally reversible and irreversible gels |
| 02/12/1992 | EP0470667A1 Composition containing a 4-quinolone derivative complexed with a divalent metal ion |
| 02/12/1992 | EP0470569A1 Intravascular embolizing agent containing angiogenesis inhibiting substance |
| 02/12/1992 | EP0470452A2 A method for the production of complexes of long chain polyunsaturated fatty acids and their derivatives, with cyclodextrins, and the resulting complexes |
| 02/12/1992 | EP0470251A1 Liquid prostaglandin composition |
| 02/12/1992 | EP0470128A1 Active carbonates of polyalkylene oxides for modification of polypeptides |
| 02/12/1992 | CN1058598A New linker for bioactive agents |
| 02/12/1992 | CN1058533A Controlled release pharmaceutical preparation |
| 02/11/1992 | US5087696 Conjugate compound |
| 02/11/1992 | US5087620 Controlled dermal penetration enhancement using imidazoles |
| 02/11/1992 | US5087616 Linked by biodegradable polymer to epidermal growth factor |
| 02/11/1992 | CA1295611C Association complex comprising pullulan and polyethylene glycol, and preparation and uses of the same |
| 02/10/1992 | CA2047884A1 Method for the production of complexes of long chain polyunsaturated fatty acids and their derivatives, with cyclodextrins, and the resulting complexes |
| 02/08/1992 | WO1992002212A2 Use of interfacially-polymerized membranes in delivery devices |
| 02/06/1992 | WO1992001802A1 Methods and apparatus for ice-medicated introduction of substances into biological material in a non-lethal manner |
| 02/06/1992 | WO1992001730A1 Novel polyamines and method for preparation thereof |
| 02/06/1992 | WO1992001718A2 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 02/06/1992 | WO1992001477A1 Polymeric drug delivery system |
| 02/06/1992 | WO1992001476A1 Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule |
| 02/06/1992 | WO1992001470A1 Target specific antibody-superantigen conjugates and their preparation |
| 02/06/1992 | WO1992001463A1 Stabilized somatotropin for parenteral administration |
| 02/06/1992 | WO1992001457A1 Products and processes for the treatment of the alimentary canal |